Showing 25,261 - 25,280 results of 49,434 for search '(( 5 ((point decrease) OR (mean decrease)) ) OR ( 50 ((mg decrease) OR (a decrease)) ))', query time: 1.37s Refine Results
  1. 25261

    <i>lin-4</i> and its targets <i>lin-14</i> and <i>lin-28</i> are expressed reciprocally during larval development. by Katherine Olsson-Carter (244338)

    Published 2010
    “…*p-value = 0.012. ***p-values<0.001 (2.5×10<sup>−5</sup> for L3 and 6.3×10<sup>−7</sup> for L4). …”
  2. 25262

    Response kinetics and relationship to Weber’s law in the m2 controller (Fig 7). by Jonas V. Grini (15374504)

    Published 2023
    “…<p>The set-point of <i>A</i> is <i>A</i><sub><i>set</i></sub>=3.0 (a) Step-wise increase of <i>k</i><sub>2</sub> from 1.0 to 5.0 at time <i>t</i>=100 at different and constant background perturbations <i>k</i><sub>4</sub> (0–80). …”
  3. 25263

    Frequency and voltage range of noise-dependent MPOs in neuropathic model. by Young-Ah Rho (162030)

    Published 2012
    “…Spike threshold was estimated as the voltage at the inflection point for <i>dV</i>/<i>dt</i>. Sample response shows progressive inactivation (decrease in <i>h</i>; <i>green</i>) and the corresponding rise in spike threshold (<i>red</i>) which eventually leads to the termination of repetitive spiking. …”
  4. 25264

    Heat knock-down time of <i>Bicyclus anynana</i> in relation to sex, larval and adult feeding treatment. by Klaus Fischer (82645)

    Published 2013
    “…<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0015284#pone-0015284-t005" target="_blank">Table 5</a>). …”
  5. 25265

    Table1_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Suppress... by Fei-lin Ge (11611192)

    Published 2021
    “…A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  6. 25266

    DataSheet3_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  7. 25267

    DataSheet4_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  8. 25268

    DataSheet1_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  9. 25269

    DataSheet6_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  10. 25270

    DataSheet5_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  11. 25271

    DataSheet2_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  12. 25272

    DataSheet7_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  13. 25273

    Activity of the small molecule PLK1, 2, and 3 inhibitor BI 2536 in preclinical models of MM in the absence of the bone microenvironment. by Douglas W. McMillin (348456)

    Published 2013
    “…<p>(A) BI 2536 (0–80 nM; 72 hrs) was tested against a panel of MM cell lines by MTT assay, the majority having IC50 values <40 nM. …”
  14. 25274

    Shoot and root responses to low phosphorus and their genotypic variability in selected cultivars of Japanese core collections of maize and soybean by Chathuri Lankani Samarasekara Muhandiram Karunarathne (17448397)

    Published 2023
    “…Ten cultivars of each species were further evaluated in a pot experiment with two P supply rates: low P (10 mg P kg<sup>−1</sup>) and high P (50mg P kg<sup>−1</sup>). …”
  15. 25275

    Prevalence of radiographic markers of femoroacetabular impingement in asymptomatic adults by Rodrigo Benedet Scheidt (10458805)

    Published 2021
    “…RESULTS: our sample consisted of 66% women, mean age of 50.4 years. The average alpha angle was 45.10°, SD=8.6. …”
  16. 25276

    Exploration of muscle loss and metabolic state during prolonged critical illness: Implications for intervention? by Liesl Wandrag (20467)

    Published 2019
    “…Starting muscle depth, 8.5cm (SD: 3.2) to end muscle depth, 6.8cm (SD: 2.2) were on average significantly different over 14 days, with mean difference -1.67cm (95%CI: -2.3 to -1cm), p<0.0001. …”
  17. 25277

    Large-scale analysis by SAGE reveals new mechanisms of oncogene action-2 by Corinne Bresson (73910)

    Published 2011
    “…The hatched bar is the mean of mRNA accumulation in the five independent experiments. 3B – Effect of v-ErbA on the expression level of the c-Myb protein. …”
  18. 25278

    Inhibition of full-length wild-type capsid polymerization kinetics by two CA binding agents. by Magdeleine Hung (158371)

    Published 2013
    “…Assembly reactions were induced by 2-fold dilution of capsid protein into buffer containing 50 mM sodium phosphate pH 7.5, 4 M NaCl at 25°C. …”
  19. 25279

    Data_Sheet_1_Preparation of nano-selenium from chestnut polysaccharide and characterization of its antioxidant activity.docx by Shanshan Wang (283009)

    Published 2023
    “…The DPPH free radical scavenging rate of purified polysaccharide fraction CP-1a was slightly enhanced, and the other rates showed a small decrease. …”
  20. 25280

    Optical imaging of luminescence for quantification of gene electrotransfer in mouse muscle and knee-1 by C Bloquel (56006)

    Published 2011
    “…For all experiments, the first measurement was performed 2 minutes after luciferin injection. Panel A: luciferin injection (2.5 mg/250 μl), n = 5 Panel B: local luciferin injection into the muscle (100 μg/40 μl) and into the knee joint (50 μg/10 μl), n= 5/organ. …”